{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:06:58Z","timestamp":1770818818717,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1124\/jpet.120.000062","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:25:12Z","timestamp":1599002712000},"page":"349-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ezetimibe Enhances Macrophage-to-Feces Reverse Cholesterol Transport in Golden Syrian Hamsters Fed a High-Cholesterol Diet"],"prefix":"10.1016","volume":"375","author":[{"given":"Fatima","family":"Kasbi-Chadli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Treguier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Briand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Sulpice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Ouguerram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.000062_bib1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science"},{"key":"10.1124\/jpet.120.000062_bib2","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.3748\/wjg.v12.i27.4369","article-title":"Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease","volume":"12","author":"Assy","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1124\/jpet.120.000062_bib3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0021-9258(17)35229-8","article-title":"cAMP stimulates cholesteryl ester clearance to high density lipoproteins in J7774 macrophages","volume":"266","author":"Bernard","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000062_bib4","first-page":"289","article-title":"The use of dyslipidemic hamsters to evaluate drug-induced alterations in reverse cholesterol transport","volume":"11","author":"Briand","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1124\/jpet.120.000062_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1752-8062.2009.00098.x","article-title":"Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol","volume":"2","author":"Briand","year":"2009","journal-title":"Clin Transl Sci"},{"key":"10.1124\/jpet.120.000062_bib6","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1194\/jlr.M016410","article-title":"Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters","volume":"52","author":"Castro-Perez","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.120.000062_bib7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.metabol.2015.02.001","article-title":"Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK\/ERK pathway rather than dipeptidyl peptidase 4 inhibition","volume":"64","author":"Chang","year":"2015","journal-title":"Metabolism"},{"key":"10.1124\/jpet.120.000062_bib8","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1161\/CIRCULATIONAHA.104.475715","article-title":"Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?","volume":"113","author":"Cuchel","year":"2006","journal-title":"Circulation"},{"key":"10.1124\/jpet.120.000062_bib9","doi-asserted-by":"crossref","first-page":"12710","DOI":"10.1074\/jbc.M409110200","article-title":"Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia","volume":"280","author":"Davies","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000062_bib10","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1016\/j.febslet.2007.11.023","article-title":"Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome","volume":"581","author":"Deushi","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.120.000062_bib11","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/jn\/135.10.2305","article-title":"Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe","volume":"135","author":"During","year":"2005","journal-title":"J Nutr"},{"key":"10.1124\/jpet.120.000062_bib12","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1194\/jlr.M400208-JLR200","article-title":"Stanol esters decrease plasma cholesterol independently of intestinal ABC sterol transporters and Niemann-Pick C1-like 1 protein gene expression","volume":"45","author":"Field","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.120.000062_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000062_bib14","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.0500269102","article-title":"The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)","volume":"102","author":"Garcia-Calvo","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.120.000062_bib15","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1038\/oby.2006.281","article-title":"Metabolic syndrome: focus on dyslipidemia","volume":"14","author":"Ginsberg","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/jpet.120.000062_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1124\/jpet.120.000062_bib17","doi-asserted-by":"crossref","first-page":"e61109","DOI":"10.1371\/journal.pone.0061109","article-title":"Omega 3 fatty acids promote macrophage reverse cholesterol transport in hamster fed high fat diet","volume":"8","author":"Kasbi Chadli","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.000062_bib18","doi-asserted-by":"crossref","first-page":"G776","DOI":"10.1152\/ajpgi.90275.2008","article-title":"Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-\/- mice","volume":"295","author":"Labont\u00e9","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.120.000062_bib19","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/ATVBAHA.117.309119","article-title":"Ezetimibe increases endogenous cholesterol excretion in humans","volume":"37","author":"Lin","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.120.000062_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI29154","article-title":"Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members","volume":"117","author":"MacArthur","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.120.000062_bib21","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0022-2275(20)40076-8","article-title":"Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3","volume":"35","author":"Mazzone","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.120.000062_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.ATV.0000018304.30943.06","article-title":"Normal production rate of apolipoprotein B in LDL receptor-deficient mice","volume":"22","author":"Millar","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.120.000062_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0009-8981(77)90355-2","article-title":"A new colorimetric method for the determination of plasma lecithin-cholesterol acyltransferase activity","volume":"75","author":"Nagasaki","year":"1977","journal-title":"Clin Chim Acta"},{"key":"10.1124\/jpet.120.000062_bib24","doi-asserted-by":"crossref","first-page":"G1043","DOI":"10.1152\/ajpgi.00250.2011","article-title":"Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance","volume":"302","author":"Naples","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.120.000062_bib25","doi-asserted-by":"crossref","first-page":"E1030","DOI":"10.1152\/ajpendo.00343.2009","article-title":"Inhibition of hepatic Niemann-Pick C1-like 1 improves hepatic insulin resistance","volume":"297","author":"Nomura","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.120.000062_bib26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2009.05.017","article-title":"Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease","volume":"51","author":"Nozaki","year":"2009","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.120.000062_bib27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCULATIONAHA.118.039415","article-title":"Ezetimibe lipid-lowering trial on prevention of atherosclerotic cardiovascular disease in 75 or older (EWTOPIA 75): a randomized, controlled trial","volume":"140","author":"Ouchi","year":"2019","journal-title":"Circulation"},{"key":"10.1124\/jpet.120.000062_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00535-010-0291-8","article-title":"Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease","volume":"46","author":"Park","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1124\/jpet.120.000062_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MOL.0000000000000473","article-title":"Transintestinal cholesterol excretion in humans","volume":"29","author":"Reeskamp","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"10.1124\/jpet.120.000062_bib30","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.20439","article-title":"ACAT2 deficiency limits cholesterol absorption in the cholesterol-fed mouse: impact on hepatic cholesterol homeostasis","volume":"40","author":"Repa","year":"2004","journal-title":"Hepatology"},{"key":"10.1124\/jpet.120.000062_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1152\/ajplegacy.1957.188.2.399","article-title":"Effect of triton on lipoprotein lipase of rat plasma","volume":"188","author":"Schotz","year":"1957","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.120.000062_bib32","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/ATVBAHA.108.165803","article-title":"Cholesterol absorption from the intestine is a major determinant of reverse cholesterol transport from peripheral tissue macrophages","volume":"28","author":"Sehayek","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.120.000062_bib33","doi-asserted-by":"crossref","first-page":"46064","DOI":"10.1074\/jbc.M108909200","article-title":"Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance","volume":"276","author":"Siri","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000062_bib34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cvr\/cvm087","article-title":"The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport","volume":"77","author":"Tchoua","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.120.000062_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2362.2011.02478.x","article-title":"Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters","volume":"41","author":"Tr\u00e9guier","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/jpet.120.000062_bib36","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.ATV.0000216750.09611.ec","article-title":"Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia","volume":"26","author":"Tremblay","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.120.000062_bib37","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbalip.2014.05.009","article-title":"Ezetimibe enhances macrophage reverse cholesterol transport in hamsters: contribution of hepato-biliary pathway","volume":"1841","author":"Uto-Kondo","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.120.000062_bib38","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2337\/diabetes.50.6.1330","article-title":"Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters","volume":"50","author":"van Heek","year":"2001","journal-title":"Diabetes"},{"key":"10.1124\/jpet.120.000062_bib39","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.3892\/mmr.2014.2623","article-title":"Ezetimibe prevents the development of non-alcoholic fatty liver disease induced by high-fat diet in C57BL\/6J mice","volume":"10","author":"Wang","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1124\/jpet.120.000062_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2018.11.016","article-title":"The important role of apolipoprotein A-II in ezetimibe driven reduction of high cholesterol diet-induced atherosclerosis","volume":"280","author":"Yan","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1124\/jpet.120.000062_bib41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2008.01.045","article-title":"Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice","volume":"584","author":"Zheng","year":"2008","journal-title":"Eur J Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652426986X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652426986X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:23:05Z","timestamp":1739964185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652426986X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S002235652426986X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000062","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ezetimibe Enhances Macrophage-to-Feces Reverse Cholesterol Transport in Golden Syrian Hamsters Fed a High-Cholesterol Diet","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}